Cancers, Vol. 16, Pages 1363: Biomarkers for Pre-Treatment Risk Stratification of Prostate Cancer Patients: A Systematic Review

Conclusion: This systematic review unveils the substantial clinical promise of using circulating biomarkers in assessing the risk for prostate cancer patients. However, the standardization of groups, categories, and biomarker validation are mandatory before this technique can be implemented. Circulating biomarkers might represent a viable alternative to currently available tools, obviating the need for tissue biopsies, and allowing for faster and more cost-effective testing, with superior analytical performance, specificity, and reproducibility.
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Systematic Review Source Type: research